CLOV vs XGN
Clover Health Investments Corp (CLOV) versus Exagen Inc (XGN) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Exagen Inc (XGN) is a diagnostics & research company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported XGN revenue for 2024-12-31 was $55.6M. Net income was -$15.1M. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. XGN currently screens at market cap $154.1M.
CLOV currently screens at market cap $1.55B. XGN currently screens at market cap $154.1M.
Not investment advice. Open the CLOV and XGN stock pages for the full models.
Not investment advice.